Ubs Asset Management Americas Inc Novavax Inc Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Novavax Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 224,325 shares of NVAX stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

224,325

Previous 254,780 11.95%

Holding current value

$2.07 Million

Previous $3.23 Million 12.16%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $326,173 - $521,085	-30,455 Reduced 11.95%	224,325 $2.83 Million
Q2 2024 Aug 13, 2024	BUY	$3.89 - $20.97 $656,301 - $3.54 Million	168,715 Added 196.03%	254,780 $3.23 Million
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $57,422 - $91,937	15,272 Added 21.57%	86,065 $411,000
Q4 2023 Feb 14, 2024	SELL	$4.8 - $7.67 $141,220 - $225,659	-29,421 Reduced 29.36%	70,793 $339,000
Q3 2023 Nov 13, 2023	SELL	$6.81 - $9.74 $223,844 - $320,153	-32,870 Reduced 24.7%	100,214 $725,000
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $193,835 - $419,976	33,652 Added 33.84%	133,084 $922,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $3,083 - $8,713	348 Added 0.35%	99,432 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $329,802 - $1.38 Million	-18,121 Reduced 15.46%	99,084 $1.8 Million
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $3.73 Million - $7.74 Million	-102,762 Reduced 46.72%	117,205 $6.03 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $63,802 - $130,753	915 Added 0.42%	219,967 $16.2 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $177,350 - $287,284	-1,318 Reduced 0.6%	219,052 $31.3 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $13.4 Million - $20.4 Million	-75,313 Reduced 25.47%	220,370 $45.7 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $15 Million - $31.9 Million	123,759 Added 71.98%	295,683 $62.8 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $3.93 Million - $11.1 Million	-34,792 Reduced 16.83%	171,924 $31.2 Million
Q4 2020 Mar 01, 2021	BUY	$78.74 - $139.5 $3.01 Million - $5.33 Million	38,185 Added 22.66%	206,716 $23.1 Million
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $9.7 Million - $21.8 Million	122,135 Added 263.24%	168,531 $18.3 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $643,048 - $3.88 Million	46,396 New	46,396 $3.87 Million
Q4 2019 Feb 14, 2020	SELL	$3.69 - $5.22 $74,320 - $105,136	-20,141 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.02 - $7.84 $18,636 - $36,346	4,636 Added 29.9%	20,141 $101,000
Q2 2019 Aug 15, 2019	BUY	$4.93 - $12.2 $76,439 - $189,161	15,505 New	15,505 $0

Others Institutions Holding NVAX

# of Institutions

291

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $722M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Novavax Inc Transaction History